The efficacy of ICIs rechallenge in advanced small cell lung cancer after progression from ICIs plus chemotherapy: A real-world study
Our study suggests that rechallenge of ICIs could be considered as a potential therapeutic strategy for advanced SCLC after progression from chemo-ICIs, particularly in patients with AR.
Authors
- Ye Tao (ORCID: https://orcid.org/0000-0001-5862-9520)
- Fen Liu (ORCID: https://orcid.org/0000-0001-9214-0016)
- Guisen Yin
- Yong Pan (ORCID: https://orcid.org/0000-0003-3199-7045)
Institutions
- Central South University (CN)
- Hunan Cancer Hospital (CN)
- Yantaishan Hospital (CN)
Publication Details
- Journal
- International Immunopharmacology
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1016/j.intimp.2025.114372
- Citations
- 6
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 6.27